[References]　酸化脂質と疾患: 検出技術開発が拓くフェロトーシス・創薬研究の進展

1. S. J. Dixon et al., Cell, 2012, 149(5), 1060-1072.
2. J. Zheng and M. Conrad, Cell Metab., 2020, 32(6), 920-937.
3. X. Z. West et al., Nature, 2010, 467(7318), 972-6.
4. M. Di Gioia, Nat. Immunol., 2020, 21(1), 42-53.
5. Y. Shimanaka et al., Nat. Med., 2017, 23(11), 1287-1297.
6. S. Hörkkö et al., J. Clin. Invest., 1996, 98, 815-825.
7. Y. Ikura et al., Hepatology, 2006, 43, 506-514.
8. X. Que et al., Nature, 2018, 558, 301-306.
9. X. Sun et al., Cell Metab., 2020, 31, 189-206.
10. Y. Imai et al., Cell, 2008, 133, 235-249.
11. A. D. Watson et al., J. Biol. Chem., 1997, 272, 13597-13607.
12. I. Zanoni et al., Science, 2016, 352, 1232-1236.
13. H. G. Colaço, Genes Immun., 2024, 25, 177-178.
14. K. I. Yamada et al., Nat. Chem. Biol., 2016, 12, 608-613.
15. M. Enoki et al., Chem. Commun., 2017, 53, 10922-10925.
16. Y. Matsuoka et al., Anal. Chem., 2020, 92, 6993-7002.
17. P. Lerksaipheng et al., Free Radic. Biol. Med., 2024, 224, 618-629.
18. Y. Matsuoka et al., Nat. Commun., 2021, 12(1), 6339.
19. K. Saito et al., Redox Ex. Med., 2023, e220024.
20. B. R. Stockwell, Cell, 2022, 185(14), 2401-2421.
21. Y. Hirata et al., Curr. Biol., 2023, 33(7), 1282-1294.
22. Y. Saimoto et al., Nat. Commun., 2025, 16, 3554.
23. R. Mori et al., Redox Biol., 2024, 73, 103186.